Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07231237 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating Solventum™ Vitrebond™ Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure
A NA study, sponsored by Solventum US.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT07231237 is a NA study that was terminated before completion, run by Solventum US. The registered enrollment target is 5 participants.
The verdict
NCT07231237, a NA study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is looking at the safety and effectiveness of Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping (DPC) on permanent teeth that have pulp exposure due either to deep cavities, trauma, or other accidental causes. Dental pulp is the part of the tooth that contains the nerves, blood vessels, and cells that keep teeth healthy. The DPC procedure is done by dentists to help preserve tooth health if there is pulp exposure during the tooth restoration or due to trauma. Participants must have at least one permanent tooth with pulp exposure that needs DPC to be eligible for the study.
Interventions
- DEVICE Vitrebond™ Pulp Protect Liner/Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-02-17 |
| Est. Completion | 2026-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07231237
The ClinicalTrials.gov registry entry for NCT07231237 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitrebond™ Pulp Protect Liner/Base is the first listed.
NCT07231237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07231237 about?
NCT07231237 is a clinical study titled "Clinical Study Evaluating Solventum™ Vitrebond™ Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure". This research study is looking at the safety and effectiveness of Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping (DPC) on permanent teeth that have pulp exposure due either to deep cavities, trauma, or other accidental causes. Dental pulp is the part of the tooth that contains...
What is the current status of trial NCT07231237?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2026-02-17. Estimated completion is 2026-04-15.
What interventions are being tested in trial NCT07231237?
The interventions under investigation include: Vitrebond™ Pulp Protect Liner/Base (DEVICE).
Who is sponsoring clinical trial NCT07231237?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.